Camilla V. Simpson's most recent trade in Spruce Biosciences Inc was a trade of 400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 400 | 400 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Dec 2025 | 400 | 0 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 362 | 362 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Dec 2025 | 362 | 0 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Dec 2025 | 309 | 0 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 309 | 309 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 173 | 173 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Dec 2025 | 173 | 0 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 133 | 133 | - | - | Stock Option (right to buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Dec 2025 | 133 | 0 | - | - | Stock Option (right to buy) | |
| GRI Bio Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2025 | 23,605 | 23,605 | - | - | Stock Option (Right to Buy) | |
| GRI Bio Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 5,994 | 5,994 | - | - | Stock Option (Right to Buy) | |
| GRI Bio Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 4,527 | 4,527 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| GRI Bio Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 30,297 | 30,297 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| GRI Bio Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 34,483 | 34,483 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 14,045 | 2,007 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Sale of securities on an exchange or to another person at price $ 16.14 per share. | 30 Apr 2021 | 14,045 | 0 | - | 16.1 | 226,664 | Common Stock |
| Spruce Biosciences Inc | Camilla V. Simpson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 30 Apr 2021 | 14,045 | 14,045 | - | 0.8 | 11,938 | Common Stock |